Summary
This work examines the effect of oral treatment of rats with the nitrofuran drugs furazolidone (FZ) and furaltadone (F) at doses of 100, 200 and 400 mg/kg for 4 days, or F in the drinking water at concentrations of 0.1, 0.2 and 0.4% w/v for 14 days, on drug metabolism in vivo. FZ at doses of 200 and 400 mg/kg, and F at a dose of 400 mg/kg or at a concentration of 0.4% w/v in water depressed growth and prolonged pentobarbitone-induced sleeping time. Treatment also significantly increased the blood concentration of metronidazole when measured 30 and 40 min after metronidazole administration. Administration of tremorine (25 mg/kg, i.p.) to control vehicle-treated rats produced within 2–3 min tremors, piloerection, profuse salivation, defecation urination and chromodacryorrhesis (red tears). The onset of appearance of these signs was delayed to 7–12 min in rats pretreated with FZ or F (100 mg/kg, 4 days) or cimetidine (50 mg/kg, i.p.) given 45 min earlier. Taken together, these results suggest that FZ and F inhibit drug metabolism in rats. Treatment with these nitrofuran drugs may alter the disposition of certain drugs which may be given concomitantly with them.
Similar content being viewed by others
References
Phillips K.F., Haley F.I. (1986): The use of furoxone: a perspective [Review]. J. Intern. Med. Res., 14, 19–29.
Sethurman S., Mahmoud M., Kareem S. (1994): Furazolidone in multi-resistant childhood typhoid fever. Ann. Trop. Paediatr., 14, 321–324.
Walzer P.D., Kim C.J., Foy J., Zhang J.L. (1991): Furazolidone and nitrofurantoin in the treatment of experimentalPneumocystis carinii pneumonia. Antimicrob. Agents Chemother., 35, 158–163.
Zheng Z.T., Wang Y.B. (1992): Treatment of peptic ulcer disease with furazolidone. J. Gastroenterol. Hepatol., 7, 533–537.
Ali B.H. (1991): Effects of nitrofurans on duodenal ulceration induced by cysteamine or indomethacin. Pharmacology, 42, 49–53.
Ali B.H. (1983): Some pharmacological and toxicological properties of furazolidone. Vet. Res. Commun., 6, 1–11.
Ali B.H. (1989): Pharmacology and toxicity of furazolidone in man and animals: some recent research. Gen. Pharmacol., 20, 557–563.
Czamecki C.M. (1980): Furazolidone-induced cardiomyopathy-biochemical model for the study of cardiac hypertrophy and congestive heart failure. Avian Dis., 24, 120–138.
Ali B.H., Idris O.F., Hamid A. (1988): Some effects of furaltadone in chickens. Proc. 4th EAVPT Congress, Budapest, pp 48–49.
Bartlet A.L., Harvey S., Klandorf H. (1990): Contrasting effects of nitrofurans on plasma corticosterone in chickens following administration as a bolus or diet additive. J. Vet. Pharmacol. Ther., 13, 261–269.
Bartlet A.L., Khan F.H. (1990): Effects of nitrofurans on adrenal cortical tissue in chickens. J. Vet. Pharmacol. Ther., 13, 206–216.
Fukuhara M., Takabatake E. (1977): The effect of nitrofuran derivatives on hepatic microsomal mixed-function oxidase activity in rats. Toxicol. Appl. Pharmacol., 42, 571–581.
Dubin M., Villamil S.H., Blumenfield P., Stoppani A.O. (1991) Inhibition of microsomal lipid peroxidation and cytochrome P-450 catalysed reactions by nitrofuran compounds. Free Rad. Res. Commun., 14, 419–431.
Ali B.H., Bartlet A.L. (1980): Inhibition of monoamine oxidase by furazolidone in chickens and the influence of alimentary flora thereon. Br. J. Pharmacol., 71, 219–224.
Czeczot H., Szeliga M.K., Bilbin M. (1992): The effect of nitrofurazone and furazolidone on induction of cytochrome-P-450 dependent monooxygenase system. Acta Biochim. Pol., 39, 128–131.
Sasaki N (1994): Effects of furazolidone on duration of righting reflex loss induced with hexobarbital and zoxazolamine in the rat. J. Vet. Med. Sci., 56, 667–670.
Urtasun R. C., Chapman J.D., Band P. et al. (1975): Phase I study of high dose metronidazole. Radiology, 117, 129–133.
Sharif S.L., Ali B.H. (1994): The effect of grapefruit juice on drug metabolism in rats. Food Chem. Toxicol., 32, 1169–1171.
Loft S. (1990): Metronidazole and antipyrine as probes for the study of foreign compound metabolism. Pharmacol. Toxicol., 66 (suppl), 1–31. 05
Vesell E.S. (1991): The model drug approach in clinical pharmacology. Clin. Pharmacol. Ther., 50, 239–248.
Crossland J. (1980): Lewis Pharmacology, 5th edn. Edinburgh, Churchill Livingstone, p. 595.
Stern V., Hollifield R.D., Wilks S., Buzard J. (1967): Anti-monoamine oxidase action of furazolidone. J. Pharm. Exp. Ther., 156, 492–499.
Ali B.H. (1983): The anti-diamine oxidase effect of furazolidone in rabbits. Comp. Biochem. Physiol., 74C, 109–110.
Hoogenbroom L.A., Tomassini O., Oorsrong M.B., Kuizer H.A. (1991): Use of pig hepatocytes to study the inhibition of monoamine oxidase by furazolidone. Food Chem. Toxicol., 29, 185–191.
Kato R., Takanaka A., Shoji H (1969): Inhibition of drug metabolizing enzymes of liver microsomes by hydrazine derivatives in relation to their lipid solubility. Jpn. J. Pharmacol., 19, 315–322.
Boobis A.R. (1990): Species variation is the response of the cytochrome P450-dependent monooxygenase system to inducers and inhibitors. Xenobiotica, 20, 1139–1161.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ali, B.H., Tanira, M.O.M. & Bashir, A.K. The effect of furazolidone and furaltadone on drug metabolism in rats. European Journal of Drug Metabolism and Pharmacokinetics 21, 327–332 (1996). https://doi.org/10.1007/BF03189734
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189734